文献速递糖尿病肥胖与代谢综合征

预测波多黎各成人胰岛素抵抗及糖尿病进展或缓解的血浆、唾液及多液体血浆-唾液代谢组学评分的发现与验证

Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
PubMed 文献 · Diabetologia · 2024-05-21

在波多黎各成人中,用弹性网络回归构建预测基线HOMA-IR的血浆、唾液及血浆-唾液代谢组学评分,并在测试集验证。血浆和多液体评分每增加1个标准差与2型糖尿病风险升高相关,唾液评分与糖尿病前期风险相关,三者均与从糖尿病前期恢复至血糖正常的可能性降低相关。

要点

  • 血浆代谢组学评分每升高1个标准差,2型糖尿病风险HR为1.99(95%CI 1.18,3.38;p=0.01)。
  • 唾液代谢组学评分与糖尿病前期风险相关,HR为1.48(95%CI 1.17,1.86;p=0.001)。
  • 调整肥胖指标后,三个评分均与从糖尿病前期恢复至血糖正常的可能性降低相关。

核心结论

  • 预测胰岛素抵抗的血浆代谢组学评分与2型糖尿病发病的关联强于唾液代谢组学评分。
  • 仅唾液代谢组学评分与糖尿病前期发病相关。

研究设计与样本

  • 在圣胡安超重成人纵向研究的波多黎各成人中,用LC/MS测定血浆(n=1051)和唾液(n=635)代谢物。
  • 用弹性网络回归在训练集(n=509)识别预测基线HOMA-IR的血浆、唾液及血浆-唾液代谢组学评分,并在测试集(n=340)验证。
  • 用多变量Cox比例风险模型估计基线代谢组学评分与3年时2型糖尿病(n=54)、糖尿病前期(n=130)及从糖尿病前期恢复至血糖正常(n=122)的关联,调整传统糖尿病相关危险因素。

主要发现

  • 血浆、唾液及血浆-唾液代谢组学评分包含来自果糖、酪氨酸、脂质和氨基酸代谢的高权重代谢物。
  • 血浆代谢组学评分每升高1个标准差,2型糖尿病风险HR为1.99(95%CI 1.18,3.38;p=0.01)。
  • 多液体血浆-唾液代谢组学评分每升高1个标准差,2型糖尿病风险HR为1.80(95%CI 1.06,3.07;p=0.03)。
  • 唾液代谢组学评分与糖尿病前期发病相关,HR为1.48(95%CI 1.17,1.86;p=0.001)。
  • 调整肥胖指标后,三个评分均与从糖尿病前期恢复至血糖正常的可能性降低相关(HR:血浆0.72,唾液0.78,多液体0.72),但调整脂质和血糖指标后关联减弱。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Many studies have examined the relationship between plasma metabolites and type 2 diabetes progression, but few have explored saliva and multi-fluid metabolites. METHODS: We used LC/MS to measure plasma (n=1051) and saliva (n=635) metabolites among Puerto Rican adults from the San Juan Overweight Adults Longitudinal Study. We used elastic net regression to identify plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting baseline HOMA-IR in a training set (n=509) and validated these scores in a testing set (n=340). We used multivariable Cox proportional hazards models to estimate HRs for the association of baseline metabolomic scores predicting insulin resistance with incident type 2 diabetes (n=54) and prediabetes (characterised by impaired glucose tolerance, impaired fasting glucose and/or high HbA1c) (n=130) at 3 years, along with regression from prediabetes to normoglycaemia (n=122), adjusting for traditional diabetes-related risk factors. RESULTS: Plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance included highly weighted metabolites from fructose, tyrosine, lipid and amino acid metabolism. Each SD increase in the plasma (HR 1.99 [95% CI 1.18, 3.38]; p=0.01) and multi-fluid (1.80 [1.06, 3.07]; p=0.03) metabolomic scores was associated with higher risk of type 2 diabetes. The saliva metabolomic score was associated with incident prediabetes (1.48 [1.17, 1.86]; p=0.001). All three metabolomic scores were significantly associated with lower likelihood of regressing from prediabetes to normoglycaemia in models adjusting for adiposity (HRs 0.72 for plasma, 0.78 for saliva and 0.72 for multi-fluid), but associations were attenuated when adjusting for lipid and glycaemic measures. CONCLUSIONS/INTERPRETATION: The plasma metabolomic score predicting insulin resistance was more strongly associated with incident type 2 diabetes than the saliva metabolomic score. Only the saliva metabolomic score was associated with incident prediabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Haslam DE, Liang L, Guo K, et al. Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults. Diabetologia. 2024. PMID: 38772919. doi:10.1007/s00125-024-06169-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。